Entries by Rebecca Mercer

Self-monitoring to improve physiotherapy care for women after surgery and treatment for breast cancer

July 13, 2020 /0 Comments/in /by

Awardee: Kendra Zadravec Graduate Program: PhD Institution: University of British Columbia Supervisor(s): Kristin Campbell ARCC Program Area(s): Competition: 2020 Project Summary: After breast cancer surgery, many women experience shoulder and arm problems, including pain, decreased shoulder mobility, muscle weakness, and persistent arm swelling (lymphedema). Research has shown that physiotherapy (PT) (more…)

User-Centric Design of a Proof-of-Concept of a Smartphone Application to Connect Cancer Caregivers with On-Demand Nursing Respite Care Services

July 13, 2020 /1 Comment/in /by

Awardee: Aimee Castro Graduate Program: PhD Institution: McGill University Supervisor(s): Argerie Tsimicalis ARCC Program Area(s): Competition: 2020 Project Summary: As medical therapies have advanced, cancer has become a chronic condition for many survivors, necessitating ongoing caregiving in the community. This caregiving is most often provided by family and friends. The (more…)

Invitation to participate in a research study: HTA use in Canada / Étude de recherche: Utilisation d’ETS au Canada

July 10, 2020 /0 Comments/in , /by

Le français suit INVITATION We invite you to participate in an online survey that asks your opinion about facilitators and barriers to the use of Health Technology Assessment (HTA) in Canada. You can access the survey here: https://maastrichtuniversity.eu.qualtrics.com/jfe/form/SV_71VXNB9baxoMQ8R The study is a collaboration between researchers from Dalhousie University, Maastricht University, (more…)

Virtual ARCC2020

July 8, 2020 /0 Comments/in /by

We are excited to officially launch Virtual ARCC2020! Starting in 2 weeks, on July 22nd, through the end of September, we will host 7 different 1 hour sessions each featuring 2-3 abstracts submitted to ARCC2020. We hope you will consider joining us for some or all of these sessions to (more…)

Updated CanREValue Interim Data Report now available!

April 21, 2020 /0 Comments/in , /by

As part of a broader engagement strategy, the CanREValue Collaboration has launched a stakeholder consultation process. In late 2019, the CanREValue Collaboration undertook public stakeholder consultation regarding the Interim Data Report developed by the CanREValue Data Working Group. From this consultation, we received 20 constructive submissions from a diverse set (more…)

New Publication: Real-world comparative effectiveness of 2nd line ipilimumab for metastatic melanoma…

April 16, 2020 /0 Comments/in , /by

ARCC and the CanREValue Collaboration are excited to share our recent study, using Ontario based real-world data to generate real-world evidence on the comparative effectiveness of 2nd line ipilimumab. Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada  Dai WF,  Beca JM, Croxford (more…)